Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-24-001039
Filing Date
2024-12-23
Accepted
2024-12-23 20:46:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8201
  Complete submission text file 0001013594-24-001039.txt   9983
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Subject) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90023 | Film No.: 241575426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 49F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL M5 07335
Business Address 49F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL M5 07335 82-2-1566-0900
SANGSANGIN INVESTMENT & SECURITIES CO., LTD. (Filed by) CIK: 0002049712 (see all company filings)

EIN.: 980243728 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SCHEDULE 13G